重症监护病房患者碳青霉烯类耐药肠杆菌科细菌肠道定植和感染的情况调查及影响因素分析
Investigation of Intestinal Colonization and Infection of Carbapenem Resistant Enterobacteriaceae in Intensive Care Unit Patients and Analysis of Influencing Factors
摘要: 目的:了解我院重症医学科(Intensive Care Unit, ICU)患者碳青霉烯类耐药肠杆菌科细菌(Carbapenem-resistant Enterobacterales, CRE)肠道定植情况,分析我院ICU患者CRE肠道定植、ICU患者CRE感染的影响因素;分析ICU患者CRE肠道定植与CRE感染的相关性。方法:收集2022年10月至2023年7月入住我院ICU并符合纳入与排除标准的197例患者,对其进行常规肛拭子筛查,记录患者的一般临床资料、生化指标等,根据筛查结果将患者分为CRE肠道定植组和CRE非定植组,根据患者此次住院期间是否发生感染,分为CRE感染组和非CRE感染组;对相关影响因素进行单因素分析及二元Logistic回归分析。结果:我院ICU患者CRE肠道定植率为10.2% (20/197),定植菌株类型以克雷伯菌属为主,耐药机制以产金属酶为主,替加环素的耐药率最低;CRE感染率为4.1% (8/197),CRE感染菌株类型以克雷伯菌属为主,耐药机制中以产丝氨酸酶占为主,替加环素的耐药率最低;格拉斯哥昏迷量表(Glasgow Coma Scale, GCS)评分偏高,转诊病房个数 ≥ 2个、入住ICU次数多、有碳青霉烯类药物暴露史、住院期间使用抗生素种类较多、天数较长,存在各种引流管是ICU患者CRE肠道定植的危险因素;转诊病房个数 ≥ 2个、住院期间抗生素使用种类 ≥ 3种,是ICU患者CRE感染的危险因素;肛拭子主动筛查与CRE感染存在一致性,肛拭子主动筛查在一定程度上可以预测CRE感染情况。结论:GCS评分偏高,转诊病房个数 ≥ 2个、入住ICU次数多、住院期间使用抗生素种类 ≥ 3个、使用天数较长,存在各种引流管的这部分ICU患者更易发生CRE肠道定植;转诊病房个数 ≥ 2个、住院期间抗生素使用种类 ≥ 3种两部分ICU患者在住院期间越易发生CRE感染;CRE感染和CRE肠道定植存在相关性,CRE肠道定植的患者更易发生CRE感染。
Abstract: Objective: To understand the intestinal colonization of Carbapenem-resistant Enterobacterales (CRE) in patients in the Intensive Care Unit (ICU) of our hospital, analyze the influencing factors of intestinal colonization of CRE and CRE infection in ICU patients, and analyze the correlation between intestinal colonization of CRE and CRE infection in ICU patients. Method: A total of 197 patients admitted to ICU of our hospital from October 2022 to July 2023 who met the inclusion and exclusion criteria were collected. Routine anal swab screening was performed on them, general clinical data and biochemical indicators of the patients were recorded, and the patients were divided into CRE intestinal colonization group and CRE non-colonization group according to the screening results. They were divided into CRE infection group and non-CRE infection group. Univariate analysis and binary Logistic regression analysis were performed for the relevant influencing factors. Results: The intestinal colonization rate of CRE in ICU patients in our hospital was 10.2% (20/197). The colonized strains were mainly Klebsiella, the resistance mechanism was mainly metalloenzyme production, and the resistance rate of tigecycline was the lowest. The infection rate of CRE was 4.1% (8/197). Klebsiella was the main type of CRE infection strain, serinase was the main resistance mechanism, and tigecycline had the lowest resistance rate. Glasgow Coma Scale (GCS) score was high, the number of referral wards was ≥2, the number of hospitalization in ICU, the history of carbapenem exposure, the number of antibiotics used during hospitalization, the number of days, the presence of various drainage tubes were the risk factors for CRE colonization in ICU patients. The number of referral wards ≥2 and the types of antibiotics used ≥3 during hospitalization were risk factors for CRE infection in ICU patients. Anal swab active screening is consistent with CRE infection, and anal swab active screening can predict CRE infection to some extent. Conclusions: Patients with high GCS score, more than 2 referred wards, more ICU admission times, ≥ 3 antibiotic types used during hospitalization, and longer use days were more likely to develop intestinal colonization of CRE. The number of referral wards ≥2 and the types of antibiotics used ≥3 during hospitalization were more likely to develop CRE infection during hospitalization. There is a correlation between CRE infection and CRE intestinal colonization, and patients with CRE intestinal colonization are more likely to develop CRE infection.
文章引用:王丽红, 董泽华, 何宏, 李静, 单亮, 苏媛, 刘涵云. 重症监护病房患者碳青霉烯类耐药肠杆菌科细菌肠道定植和感染的情况调查及影响因素分析[J]. 临床医学进展, 2024, 14(5): 315-326. https://doi.org/10.12677/acm.2024.1451429

参考文献

[1] Centers for Disease Control and Prevention. CRE Technical Information.
https://www.cdc.gov/hai/organisms/cre/technical-info.html
[2] Jean, S.S., Harnod, D. and Hsueh, P.R. (2022) Global Threat of Carbapenem-Resistant Gram-Negative Bacteria. Frontiers in Cellular and Infection Microbiology, 12, Article ID: 823684. [Google Scholar] [CrossRef] [PubMed]
[3] 胡付品, 郭燕, 朱德妹, 等. 2021年CHINET中国细菌耐药监测[J]. 中国感染与化疗杂志, 2022, 22(5): 521-530.
[4] Dickstein, Y., Edelman, R., Dror, T., et al. (2016) Carbapenem-Resistant Enterobacteriaceae Colonization and Infection in Critically Ill Patients: A Retrospective Matched Cohort Comparison with Non-Carriers. Journal of Hospital Infection, 94, 54-59. [Google Scholar] [CrossRef] [PubMed]
[5] 陈善建, 曾勇彬, 杨滨. 碳青霉烯类耐药肠杆菌科细菌无症状携带者主动筛查的研究进展[J]. 临床检验杂志, 2018, 36(9): 675-679.
[6] Richter, S.S. and Marchaim, D. (2017) Screening for Carbapenem-Resistant Enterobacteriaceae: Who, When, and How? Virulence, 8, 417-426. [Google Scholar] [CrossRef] [PubMed]
[7] Campos-Madueno, E.I., Moradi, M., Eddoubaji, Y., et al. (2023) Intestinal Colonization with Multidrug-Resistant Enterobacterales: Screening, Epidemiology, Clinical Impact, and Strategies to Decolonize Carriers. European Journal of Clinical Microbiology & Infectious Diseases, 42, 229-254. [Google Scholar] [CrossRef] [PubMed]
[8] 杨立顺, 李东霞, 耿婕. 我国抗生素滥用研究现状与热点——基于科学知识图谱的可视化分析[J]. 甘肃科技, 2021, 37(4): 34-37.
[9] Meredith, H.R., Kularatna, S., Nagaro, K., et al. (2021) Colonization with Multidrug-Resistant Enterobacteriaceae among Infants: An Observational Study in Southern Sri Lanka. Antimicrobial Resistance & Infection Control, 10, Article No. 72. [Google Scholar] [CrossRef] [PubMed]
[10] 黄细莲, 吴盛海, 施鹏飞, 等. 血液科患者肠道碳青霉烯类耐药的肠杆菌科细菌主动筛查及其效果评价[J]. 中华血液学杂志, 2020, 41(11): 932-936.
[11] Magiorakos, A.P., Burns, K., Rodríguez Baño, J., et al. (2017) Infection and Control Measures and Tools for the Prevention of Entry of Carbapenem-Resistant Enterobacteriaceae into Healthcare Settings: Guidance from the European Centre for Disease Prevention and Control. Antimicrobial Resistance & Infection Control, 6, Article No. 113. [Google Scholar] [CrossRef] [PubMed]
[12] CHINET. CHINET中国细菌耐药监测结果(2022年1-12月) [EB/OL].
https://www.chinets.com/Data/AntibioticDrugFast, 2024-05-07.
[13] Tzouvelekis, L.S., Markogiannakis, A., Psichogiou M, et al. (2012) Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: An Evolving Crisis of Global Dimensions. Clinical Microbiology Reviews, 25, 682-707. [Google Scholar] [CrossRef
[14] 喻华, 徐雪松, 李敏, 等. 肠杆菌目细菌碳青霉烯酶的实验室检测和临床报告规范专家共识(第二版) [J]. 中国感染与化疗杂志, 2022, 22(4): 463-474.
[15] Ezadi, F., Jamali, A., Heidari, A., et al. (2020) Heteroresistance to Colistin in Oxacillinase-Producing Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates from Gorgan, Northern Iran. Journal of Global Antimicrobial Resistance, 21, 380-385. [Google Scholar] [CrossRef] [PubMed]
[16] 王丹, 朱丹, 陈虹, 等. 综合ICU住院患者多重耐药菌医院感染与经济负担[J]. 中国感染控制杂志, 2019, 18(7): 648-653.
[17] Himmelsbach, V., Knabe, M., Ferstl, P.G., et al. (2022) Colonization with Multidrug-Resistant Organisms Impairs Survival in Patients with Hepatocellular Carcinoma. Journal of Cancer Research and Clinical Oncology, 148, 1465-1472. [Google Scholar] [CrossRef] [PubMed]
[18] Stratmann, J.A., Lacko, R., Ballo, O., et al. (2020) Colonization with Multi-Drug-Resistant Organisms Negatively Impacts Survival in Patients with Non-Small Cell Lung Cancer. PLOS ONE, 15, e0242544. [Google Scholar] [CrossRef] [PubMed]
[19] Marimuthu, K., Venkatachalam, I., Koh, V., et al. (2022) Whole Genome Sequencing Reveals Hidden Transmission of Carbapenemase-Producing Enterobacterales. Nature Communications, 13, Article No. 3052. [Google Scholar] [CrossRef] [PubMed]
[20] Spyridopoulou, K., Psichogiou, M., Sypsa, V., et al. (2020) Containing Carbapenemase-Producing Klebsiella pneumoniae in an Endemic Setting. Antimicrobial Resistance & Infection Control, 9, Article No. 102. [Google Scholar] [CrossRef] [PubMed]
[21] Yi, J. and Kim, K.H. (2021) Identification and Infection Control of Carbapenem-Resistant Enterobacterales in Intensive Care Units. Acute and Critical Care, 36, 175-184. [Google Scholar] [CrossRef] [PubMed]
[22] Banach, D.B., Bearman, G., Barnden, M., et al. (2018) Duration of Contact Precautions for Acute-Care Settings. Infection Control & Hospital Epidemiology, 39, 127-144. [Google Scholar] [CrossRef] [PubMed]
[23] 龙永艳, 倪贤生, 李端, 等. 食品从业人员肠道细菌CTX-M型超广谱β-内酰胺酶的携带状况研究[J]. 疾病监测, 2016, 31(5): 433-436.
[24] Stege, P.B., Hordijk, J., Shetty, S.A., et al. (2022) Impact of Long-Term Dietary Habits on the Human Gut Resistome in the Dutch Population. Scientific Reports, 12, Article No. 1892. [Google Scholar] [CrossRef] [PubMed]
[25] Ho, K.W., Ng, W.T., Ip, M., et al. (2016) Active Surveillance of Carbapenem-Resistant Enterobacteriaceae in Intensive Care Units: Is It Cost-Effective in a Nonendemic Region? American Journal of Infection Control, 44, 394-399. [Google Scholar] [CrossRef] [PubMed]